找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Alternative Approaches to Human Blood Resources in Clinical Practice; Proceedings of the T C. Th. Smit Sibinga,P. C. Das,J. C. Fratantoni C

[復(fù)制鏈接]
樓主: mortality
21#
發(fā)表于 2025-3-25 04:40:02 | 只看該作者
https://doi.org/10.1007/978-3-662-06599-0 a clear clinical question and then relevant clinical articles will be searched for, critically appraised (evaluated) for validity and usefulness and the results are finally implemented in clinical practice [1–4].
22#
發(fā)表于 2025-3-25 10:31:06 | 只看該作者
23#
發(fā)表于 2025-3-25 11:41:29 | 只看該作者
Die Kollapstherapie der Lungentuberkulose,(or expected) blood loss occurred during surgery, the patient would be in less danger of suffering deficient O. delivery to tissue. Guidelines for the transfusion of blood or packed red cells in the face of severe blood loss have been less well defined.
24#
發(fā)表于 2025-3-25 16:59:17 | 只看該作者
The Role of O2 Transport in the Development of the Transfusion Trigger(or expected) blood loss occurred during surgery, the patient would be in less danger of suffering deficient O. delivery to tissue. Guidelines for the transfusion of blood or packed red cells in the face of severe blood loss have been less well defined.
25#
發(fā)表于 2025-3-25 20:39:53 | 只看該作者
26#
發(fā)表于 2025-3-26 00:46:28 | 只看該作者
Evidence-Based Transfusion Medicine or the Need to Evaluate Clinical Outcome a clear clinical question and then relevant clinical articles will be searched for, critically appraised (evaluated) for validity and usefulness and the results are finally implemented in clinical practice [1–4].
27#
發(fā)表于 2025-3-26 04:44:57 | 只看該作者
The Development of Synthocytes?, a Novel Platelet Substituteet transfusion include a reduced risk of blood borne virus transmission, no risk of alloimmunogenic reactions, an increased shelf life and therefore a more cost effective, more easily managed therapy.
28#
發(fā)表于 2025-3-26 09:09:57 | 只看該作者
Conference proceedings 1998development of alternative approaches in thisrapidly developing area. In clinical medicine conventional blood andits components are used in supportive therapies dependent on thechoice of apparent uncritical trigger factors. A compounding factor isdepth of prospective clinical trials for evidence. Su
29#
發(fā)表于 2025-3-26 15:59:38 | 只看該作者
30#
發(fā)表于 2025-3-26 17:08:21 | 只看該作者
Warum es diese Patientenleitlinie gibt,perative haemoglobin level or platelet transfusion level, the preferences of opinion leaders in the local clinical community [7], the availability of a transfusion committee with an authoritative surveillance system, variations in supply or in local or regional risks or public perceptions of those risks.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 18:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
托克托县| 浮山县| 庆安县| 麟游县| 申扎县| 扶余县| 平凉市| 大城县| 蒙阴县| 湖南省| 乐都县| 邢台县| 宜兰市| 景泰县| 历史| 贡山| 加查县| 达州市| 桃江县| 萝北县| 苗栗市| 商河县| 鸡西市| 兴安县| 张北县| 会宁县| 洛宁县| 乌鲁木齐县| 吉木萨尔县| 榕江县| 西城区| 社旗县| 祁连县| 轮台县| 时尚| 台中市| 临泽县| 江川县| 山丹县| 丘北县| 措美县|